Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Danny Gibson"'
Autor:
Trung N. Tran, MD, PhD, Heath Heatley, PhD, Jennifer Rowell, MSc, Jeffrey Shi Kai Chan, MBChB, MPH, Arnaud Bourdin, MD, PhD, Jatin Chapaneri, MD, Benjamin Emmanuel, PhD, Danny Gibson, MSc, David J. Jackson, MRCP, Andrew N. Menzies-Gow, FRCPi, Ruth Murray, PhD, Derek Skinner, MSc, David B. Price, FRCGP
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 2, Pp 100225- (2024)
Background: Increasing frequency of intermittent oral corticosteroid (OCS) prescription and cumulative OCS exposure increase the risk of OCS-related adverse outcomes. Objective: We sought to describe the evolution and trajectory of intermittent OCS p
Externí odkaz:
https://doaj.org/article/a6b326d0480546b0b054b4170e457828
Autor:
Heide A. Stirnadel-Farrant, Sarowar M. Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham, Sue Langham, Mihail Samnaliev
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1183-1197 (2023)
Abstract Introduction This analysis compared healthcare resource use (HCRU) and costs associated with incident organ damage in a cohort of adult patients with systemic lupus erythematosus (SLE). Methods Incident SLE cases were identified (Clinical Pr
Externí odkaz:
https://doaj.org/article/225ac143668d4ac5a190ba3d0c663488
Autor:
Heide A. Stirnadel-Farrant, Sarowar M. Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham, Sue Langham, Mihail Samnaliev
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1167-1182 (2023)
Abstract Introduction This analysis was conducted to assess the incidence of adverse clinical outcomes, healthcare resource use (HCRU), and the costs associated with systemic corticosteroid (SCS) use in adults with systemic lupus erythematosus (SLE)
Externí odkaz:
https://doaj.org/article/51fd9ce8e6404aaebeea68995f80f682
Autor:
Darush Attar-Zadeh, Toby Capstick, Deborah Leese, Sofie Arnetorp, Eleni Rapsomaniki, Keith Peres Da Costa, Ekaterina Maslova, Yang Xu, Danny Gibson, Jennifer K Quint
Publikováno v:
BJGP Open, Vol 7, Iss 3 (2023)
Background: Poor asthma control is associated with high short-acting β2-agonist (SABA) use. Aim: To assess asthma-related healthcare resource utilisation (HCRU) and medication costs associated with high versus low SABA prescriptions in the UK. Desig
Externí odkaz:
https://doaj.org/article/665a0cc002ec47c2a96b4e583a651a3a
Autor:
David Price, Joan B. Soriano, Sarowar Golam, Elizabeth V. Hillyer, Danny Gibson, Marjan Kerkhof, Trung N. Tran
Publikováno v:
Thorax
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
BackgroundLittle is known about the prevalence of severe, uncontrolled eosinophilic asthma (SUEA) and associated costs.AimsWe sought to determine the prevalence of SUEA and compare asthma-related healthcare resource use (HCRU) and associated costs wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b491de5adc090b56bb31231f52185713
https://doi.org/10.1136/thoraxjnl-2017-210531
https://doi.org/10.1136/thoraxjnl-2017-210531
Autor:
Karen Coulton, Mohsen Sadatsafavi, Danny Gibson, Sofie Arnetorp, Caitlin Smare, Kirsty Hounsell, J. Mark FitzGerald
Publikováno v:
Ethics and economics.
Objective: To estimate the cost-effectiveness of as-needed budesonide/formoterol (BUD/F; Symbicort® Turbuhaler®) vs daily low-dose inhaled budesonide (BUD) + short-acting s2-agonist (SABA) as reliever in mild asthma patients for whom low-dose ICS m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26cba07678cde7c6f985e8f3e266a46b
https://doi.org/10.1183/13993003.congress-2019.pa1964
https://doi.org/10.1183/13993003.congress-2019.pa1964
Autor:
J. Mark FitzGerald, Mohsen Sadatsafavi, Sofie Arnetorp, Danny Gibson, Karen Coulton, Kirsty Hounsell, Caitlin Smare, Sarowar Golam
Publikováno v:
Respiratory Medicine. 171:106079
Background As-needed budesonide/formoterol is effective in patients with mild asthma for whom low-dose inhaled corticosteroid (ICS) maintenance therapy is appropriate. We assessed the cost-effectiveness of this regimen versus maintenance low-dose ICS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::561968af1eaaa9254b2f6a0d22715265
https://doi.org/10.1016/j.rmed.2020.106079
https://doi.org/10.1016/j.rmed.2020.106079
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Chris Kiff,1 Sandrine Ruiz,2 Nebibe Varol,3 Danny Gibson,4 Andrew Davies,1 Debasree Purkayastha5 1ICON plc, Abingdon, UK; 2AstraZeneca, Barcelona, Spain; 3AstraZeneca, Cambridge, UK; 4AstraZeneca, Luton, UK; 5Phastar, Manchester, UK Purpose: Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e774259ad0146cfe67932679cd3f28
https://www.dovepress.com/cost-effectiveness-of-roflumilast-as-an-add-on-to-triple-inhaled-thera-peer-reviewed-article-COPD
https://www.dovepress.com/cost-effectiveness-of-roflumilast-as-an-add-on-to-triple-inhaled-thera-peer-reviewed-article-COPD
Autor:
Danny, Gibson
Publikováno v:
Health estate. 63(9)
Italy is well-known for its creative flair and contemporary design, but does this creativity translate to the healthcare sector? Having recently visited several Italian hospitals, Danny Gibson, technical director at international healthcare consultan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2aebc287a5ccc39e056a2a0fb8f3b4de
https://pubmed.ncbi.nlm.nih.gov/19911562
https://pubmed.ncbi.nlm.nih.gov/19911562